C3a and C5a plasma concentrations in patients with diabetic retinopathy: a cross-sectional study. [PDF]
Dias PB +4 more
europepmc +1 more source
Crystal structures of the homologues diethyl and dimethyl (10<i>H</i>-indeno-[1,2-<i>b</i>]quinoxalin-11-yl)phospho-nate: use of non-spherical scattering factors. [PDF]
Eldeken GA +6 more
europepmc +1 more source
The Role of Complement Component C5a in the Pathogenesis of Diabetic Kidney Disease: A New Kid on the Block? [PDF]
Geladari V +4 more
europepmc +1 more source
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis. [PDF]
Furlan R +28 more
europepmc +1 more source
Complement system in cancer: friend or foe of immunotherapy. [PDF]
Shah HK +6 more
europepmc +1 more source
Crystal structure of (<i>Z</i>)-3-{2-[(<i>Z</i>)-11<i>H</i>-indeno[1,2-<i>b</i>]quinoxalin-11-yl-idene]hydrazin-yl}-<i>N</i>-phenyl-but-2-enamide monohydrate. [PDF]
Eldeken GA +6 more
europepmc +1 more source
The Intracellular C5a-mtC5aR1 Axis Promotes Necroptosis in Dry Eye Through DRP1-Mediated Mitochondrial Dysfunction. [PDF]
Wang L +8 more
europepmc +1 more source
The Complement System in ANCA-Associated Vasculitis: Mechanistic Insights, Therapeutic Horizons, and Unmet Clinical Needs. [PDF]
Sunmboye K, Millan P.
europepmc +1 more source
Complement and inflammasome crosstalk in chronic inflammation. [PDF]
Janžič L, Kouter K.
europepmc +1 more source
The novel B-cell epitope peptide vaccine, MAX449, exhibits significant anti-tumor efficacy and enhances the therapeutic effects of PD-1 antibodies on tumors by modulating the activity of PMN-MDSCs. [PDF]
Yang H +14 more
europepmc +1 more source

